Cargando…
Circulating fibrocyte levels correlate with infarct size in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention()
STUDY OBJECTIVE: Infarct size is a strong predictor of outcomes after ST elevation myocardial infarction (STEMI). Circulating fibrocytes are bone marrow-derived progenitor cells associated with fibrotic processes. We tested whether fibrocytes correlate with infarct size in STEMI patients treated wit...
Autores principales: | Elzeneini, Mohammed, Al-Ani, Mohammad, Peters, Anthony E., Burdick, Marie D., Yang, Ning, Salerno, Michael, Mehrad, Borna, Keeley, Ellen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786221/ https://www.ncbi.nlm.nih.gov/pubmed/35079723 http://dx.doi.org/10.1016/j.ahjo.2021.100071 |
Ejemplares similares
-
Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction
por: Hofbauer, Thomas M., et al.
Publicado: (2019) -
The role of fibrocytes in fibrotic diseases of the lungs and heart
por: Keeley, Ellen C, et al.
Publicado: (2011) -
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
por: Odackal, John, et al.
Publicado: (2020) -
Left Ventricular Strain Is Associated With Myocardial Recovery Following ST-Elevation Myocardial Infarction, a Prospective Longitudinal CMR Study
por: Taha, Mohamad B., et al.
Publicado: (2022) -
Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial
por: Gomez-Manjarres, Diana C., et al.
Publicado: (2023)